Reduction of Hepatitis B Surface Antigen May Be More Significant in PEGylated Interferon-Alpha Therapy Combined with Nucleotide Analogues than Combined with Nucleoside Analogues in Chronic Hepatitis B Patients: A Propensity Score Matching Study.

Published in: Canadian journal of gastroenterology & hepatology (2022)

plus NTs may lead to more HBsAg reduction, especially in HBeAg-positive and "add-on" patients.

Keyphrases